BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 54 filers reported holding BURNING ROCK BIOTECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $205,757 | -54.9% | 212,121 | 0.0% | 0.02% | -57.7% |
Q2 2023 | $456,060 | -23.5% | 212,121 | 0.0% | 0.05% | -17.5% |
Q1 2023 | $596,060 | +24.9% | 212,121 | 0.0% | 0.06% | +31.2% |
Q4 2022 | $477,272 | -5.9% | 212,121 | 0.0% | 0.05% | -11.1% |
Q3 2022 | $507,000 | -17.8% | 212,121 | 0.0% | 0.05% | -5.3% |
Q2 2022 | $617,000 | -68.7% | 212,121 | 0.0% | 0.06% | -76.8% |
Q1 2022 | $1,971,000 | -2.5% | 212,121 | 0.0% | 0.25% | +35.9% |
Q4 2021 | $2,022,000 | -46.7% | 212,121 | 0.0% | 0.18% | -46.8% |
Q3 2021 | $3,793,000 | -39.3% | 212,121 | 0.0% | 0.34% | -21.8% |
Q2 2021 | $6,249,000 | +9.4% | 212,121 | 0.0% | 0.44% | +2.6% |
Q1 2021 | $5,710,000 | +16.5% | 212,121 | 0.0% | 0.42% | +3.2% |
Q4 2020 | $4,900,000 | -7.9% | 212,121 | 0.0% | 0.41% | -47.0% |
Q3 2020 | $5,320,000 | -7.1% | 212,121 | 0.0% | 0.78% | -23.8% |
Q2 2020 | $5,729,000 | – | 212,121 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |